Results from the VENUS HF first-in-human early feasibility study shows Abiomed’s preCARDIA occlusion device promotes decongestion in patients with acutely decompensated heart failure, the company announced on 12 January.
The preCARDIA system is designed to reduce pressure on the heart and lungs by intermittently occluding the superior vena cava,...